Credit Suisse’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-163,890
| Closed | -$15.6M | – | 4559 |
|
|
2021
Q4 | $15.6M | Buy |
163,890
+2,385
| +1% | +$226K | 0.01% | 1217 |
|
|
2021
Q3 | $15.3M | Buy |
161,505
+42,245
| +35% | +$3.99M | 0.01% | 1242 |
|
|
2021
Q2 | $11.2M | Sell |
119,260
-6,515
| -5% | -$614K | 0.01% | 1488 |
|
|
2021
Q1 | $11.7M | Buy |
125,775
+106,458
| +551% | +$9.98M | 0.01% | 1477 |
|
|
2020
Q4 | $1.6M | Buy |
19,317
+4,690
| +32% | +$371K | ﹤0.01% | 2998 |
|
|
2020
Q3 | $1.11M | Sell |
14,627
-3,032
| -17% | -$225K | ﹤0.01% | 2856 |
|
|
2020
Q2 | $1.29M | Buy |
17,659
+1,094
| +7% | +$70K | ﹤0.01% | 2726 |
|
|
2020
Q1 | $797K | Sell |
16,565
-10,558
| -39% | -$679K | ﹤0.01% | 2827 |
|
|
2019
Q4 | $2.12M | Buy |
27,123
+5,121
| +23% | +$360K | ﹤0.01% | 2552 |
|
|
2019
Q3 | $1.37M | Buy |
22,002
+6,755
| +44% | +$450K | ﹤0.01% | 2775 |
|
|
2019
Q2 | $1.13M | Sell |
15,247
-3,474
| -19% | -$234K | ﹤0.01% | 2851 |
|
|
2019
Q1 | $1.24M | Buy |
18,721
+1,293
| +7% | +$83K | ﹤0.01% | 2719 |
|
|
2018
Q4 | $991K | Buy |
17,428
+262
| +2% | +$16.2K | ﹤0.01% | 2780 |
|
|
2018
Q3 | $1.24M | Sell |
17,166
-5,462
| -24% | -$439K | ﹤0.01% | 2711 |
|
|
2018
Q2 | $2.17M | Sell |
22,628
-7,906
| -26% | -$758K | ﹤0.01% | 2378 |
|
|
2018
Q1 | $3.27M | Sell |
30,534
-7,291
| -19% | -$732K | ﹤0.01% | 2027 |
|
|
2017
Q4 | $3.65M | Buy |
37,825
+3,339
| +10% | +$295K | ﹤0.01% | 1993 |
|
|
2017
Q3 | $2.98M | Buy |
34,486
+23,023
| +201% | +$1.81M | ﹤0.01% | 2209 |
|
|
2017
Q2 | $836K | Sell |
11,463
-34,719
| -75% | -$2.44M | ﹤0.01% | 2809 |
|
|
2017
Q1 | $3.19M | Sell |
46,182
-5,995
| -11% | -$438K | ﹤0.01% | 1990 |
|
|
2016
Q4 | $3.93M | Sell |
52,177
-16,422
| -24% | -$1.05M | ﹤0.01% | 1837 |
|
|
2016
Q3 | $3.69M | Buy |
68,599
+20,774
| +43% | +$1.25M | ﹤0.01% | 1890 |
|
|
2016
Q2 | $3.15M | Buy |
47,825
+7,149
| +18% | +$481K | ﹤0.01% | 2004 |
|
|
2016
Q1 | $2.76M | Buy |
40,676
+11,885
| +41% | +$715K | ﹤0.01% | 1971 |
|
|
2015
Q4 | $1.78M | Sell |
28,791
-18,042
| -39% | -$969K | ﹤0.01% | 2368 |
|
|
2015
Q3 | $2.6M | Sell |
46,833
-8,613
| -16% | -$521K | ﹤0.01% | 2062 |
|
|
2015
Q2 | $3.88M | Buy |
55,446
+7,981
| +17% | +$543K | ﹤0.01% | 1957 |
|
|
2015
Q1 | $3.36M | Sell |
47,465
-7,688
| -14% | -$484K | ﹤0.01% | 1984 |
|
|
2014
Q4 | $3.31M | Sell |
55,153
-1,666
| -3% | -$98.4K | ﹤0.01% | 2117 |
|
|
2014
Q3 | $3.11M | Sell |
56,819
-78,082
| -58% | -$4.48M | ﹤0.01% | 2132 |
|
|
2014
Q2 | $8.4M | Buy |
134,901
+34,433
| +34% | +$2.02M | 0.01% | 1532 |
|
|
2014
Q1 | $5.96M | Sell |
100,468
-21,075
| -17% | -$1.26M | 0.01% | 1608 |
|
|
2013
Q4 | $7.28M | Buy |
121,543
+37,404
| +44% | +$2.23M | 0.01% | 1512 |
|
|
2013
Q3 | $5.04M | Buy |
84,139
+24,860
| +42% | +$1.44M | 0.01% | 1627 |
|
|
2013
Q2 | $3.32M | Buy |
+59,279
| New | +$3.1M | ﹤0.01% | 1895 |
|
Credit Suisse's MGLN Position: Q1 2022 in Review
Credit Suisse sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 163,890 shares — an estimated $15.6M sold.
Credit Suisse first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $15.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- Credit Suisse reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- Credit Suisse sold 163,890 Magellan Health Services, Inc. shares in Q1 2022, an estimated $15.6M.
- Credit Suisse first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- Credit Suisse's Magellan Health Services, Inc. position peaked at $15.6M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.